Chattem Inc D/B/A Opella
NJ · 4 filings, 2025
Lobbying spend · 2025
$730K
to shape legislation
About the organization
Chattem, Inc., doing business as Opella North America, is an American, Chattanooga, Tennessee-based, producer and marketer of over-the-counter healthcare products, toiletries, dietary supplements, topical analgesics, and medicated skin care products. The company is a subsidiary of the French multinational pharmaceutical company Sanofi until 2024, now a subsidiary of the French-American multinational pharmaceutical company Opella. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Trade (domestic/foreign) · Taxation/Internal Revenue Code · Consumer Issues/Safety/Products
2Through these firms · 1
CHATTEM, INC D/B/A OPELLA
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…